Unique ID issued by UMIN | UMIN000047648 |
---|---|
Receipt number | R000054332 |
Scientific Title | Verification of the usefulness of soft Micro Pore Filter: S-MPF, a filtration membrane that separates novel rare cells, in the extraction of peripheral blood circulation tumor cells in lung cancer patients |
Date of disclosure of the study information | 2022/05/04 |
Last modified on | 2022/11/03 10:34:17 |
Verification of the usefulness of soft Micro Pore Filter: S-MPF, a filtration membrane that separates novel rare cells, in the extraction of peripheral blood circulation tumor cells (CTC) in lung cancer patients
CTC Filter Test
Verification of the usefulness of soft Micro Pore Filter: S-MPF, a filtration membrane that separates novel rare cells, in the extraction of peripheral blood circulation tumor cells in lung cancer patients
CTC Filter Test
Japan |
Lung cancer
Chest surgery |
Malignancy
NO
To verify the usefulness of a filtration membrane (Soft Micro Pore Filter: S-MPF) (patented application P531131) that separates new rare cells in the extraction of peripheral blood circulation tumor cells.
Efficacy
CTC detection rate
Interventional
Single arm
Non-randomized
Open -no one is blinded
Uncontrolled
1
Diagnosis
Maneuver |
CTC extraction by S-MPF: 15ml whole blood
20 | years-old | <= |
85 | years-old | >= |
Male and Female
1) It has been diagnosed as non-small cell lung cancer with strong probability in the clinical diagnosis.
2) CT-solid tumor and tumor diameter >2.1cm or CEA>7.5 ng/ml or SUVmax>2.9
3) The age of registration is 20 years old or older and 85 years old or younger.
4) Ecog performance status 0 or 1.
5) No history of chemotherapy or radiation therapy for the chest, including treatment for other cancer species. However, the history of hormonal therapy is acceptable.
6) Complete all of the following with the test results within 30 days before the registration date. WBC>3,000/mm3,<12,000/mm3 Hb<9.0g/dl, Platelet count>10x104 /mm3, AST<100IU/L, ALT<100IU/L Total bilirubin<1.5mg/dL Serum creatinine<1.5mg/dL
7) A case in which the patient's consent is written about the participation of this study
1) Active malignant tumors (simultaneous malignant tumors and hesichotic malignancies with a disease-free period of less than 5 years). However, lesions equivalent to Carcinoma in situ (intraepithelial cancer) and intramucosal cancer, which are judged to be cured by topical treatment, are not included in active malignant tumors).
2) Patients with infectious diseases requiring systemic treatment, including HIV, HBV, and HCV infections.
3) Without using an antipyretic, there is a fever of 38 centi digree or more at axillary temperature within 24 hours before registration.
4) Continuous systemic administration (internal or intravenous) of steroids or other immunosuppressants.
5) Cases in which the attending physician deems it inappropriate to carry out this study
25
1st name | Noriyoshi |
Middle name | |
Last name | Sawabata |
Nara Medical University
Thoracic and Cardiovascular Surgery
634-8522
840 Shijo-cho Kashihara, Nara
+819019654730
nsawabata@hotmail.com
1st name | Noriyoshi |
Middle name | |
Last name | Sawabata |
Nara Medical University
Thoracic and Cardiovascular Surgery
634-8522
840 Shijo-cho Kashihara, Nara
+819019654730
nsawabata@hotmail.com
Nara Medical University
Nara Medical University
Local Government
Nara Medical University
840 shijo-cho Nara, Japan
+81744223051
nsawabata@naramed-u.ac.jp
NO
2022 | Year | 05 | Month | 04 | Day |
Unpublished
23
In order to prove the tolerability of S-MPF in clinical practice, a prospective CTC detection rate study was conducted, and the detection rate was almost the same as that of the conventional method (ScreenCell) of 63.4% (33/52) of 63.4% (33/52).
2022 | Year | 05 | Month | 23 | Day |
2022 | Year | 12 | Month | 01 | Day |
No longer recruiting
2021 | Year | 07 | Month | 19 | Day |
2021 | Year | 10 | Month | 31 | Day |
2021 | Year | 11 | Month | 09 | Day |
2022 | Year | 05 | Month | 30 | Day |
2022 | Year | 05 | Month | 31 | Day |
2023 | Year | 06 | Month | 30 | Day |
2022 | Year | 05 | Month | 04 | Day |
2022 | Year | 11 | Month | 03 | Day |
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000054332
Research Plan | |
---|---|
Registered date | File name |
2023/05/05 | S-MPF 臨床研究(R1 SAWABATA).docx |
Research case data specifications | |
---|---|
Registered date | File name |
2023/05/05 | 登録票.xlsx |
Research case data | |
---|---|
Registered date | File name |
2023/05/05 | S-MPF 登録票 R.xlsx |